Related references
Note: Only part of the references are listed.Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
Mats Remberger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning
Sophie Servais et al.
TRANSFUSION AND APHERESIS SCIENCE (2011)
Availability of Cord Blood Extends Allogeneic Hematopoietic Stem Cell Transplant Access to Racial and Ethnic Minorities
Juliet N. Barker et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.
Ted A. Gooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313
Michael A. Pulsipher et al.
BLOOD (2009)
Reduced-intensity conditioning follow by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders
Ginna G. Laport et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Advances in the selection of HLA-compatible donors: Refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry
Stephen Spellman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Efforts of the United States' National Marrow Donor Program and Registry to improve utilization and representation of minority donors
K. A. Johansen et al.
TRANSFUSION MEDICINE (2008)
Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia
Sergio A. Giralt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
Elihu Estey et al.
BLOOD (2007)
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity
A Shimoni et al.
LEUKEMIA (2006)
Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors
C Kasper et al.
BONE MARROW TRANSPLANTATION (2004)
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
G Yanik et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
